Solid Biosciences Inc. is a leading life sciences company based in Cambridge, Massachusetts, focused on developing innovative gene therapies for Duchenne muscular dystrophy (DMD), a debilitating genetic disease primarily affecting young boys. The company is dedicated to addressing critical unmet medical needs and is advancing its robust pipeline aimed at restoring functional dystrophin to enhance patient outcomes. By leveraging cutting-edge translational science and fostering strategic collaborations within the DMD community, Solid Biosciences aims to transform therapeutic approaches for rare genetic disorders and improve the quality of life for affected individuals. Show more

Location: 500 RUTHERFORD AVENUE, CHARLESTOWN, MA, UNITED STATES, 02129, Charlestown, MA, 02129, USA | Website: https://www.solidbio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

503.3M

52 Wk Range

$2.41 - $7.37

Previous Close

$6.46

Open

$6.40

Volume

1,011,933

Day Range

$6.35 - $6.56

Enterprise Value

289.1M

Cash

61.36M

Avg Qtr Burn

-33.47M

Insider Ownership

0.56%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SGT-003 Details Duchenne muscular dystrophy (DMD)	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-212 (dual route) Details Friedreich’s Ataxia	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-501 (Cardiac Gene Therapy) Details Catecholaminergic Polymorphic Ventricular Tachycardia, Heart disease, Gene & Cell therapies	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-001 (Microdystrophin Gene Transfer) Details Genetic disorder, Muscle weakness, Muscle degeneration	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.